{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:16:45Z","timestamp":1778102205631,"version":"3.51.4"},"reference-count":10,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,8,31]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>Personalised medicine is a key goal across medical specialties today: using biomarkers and knowledge of pathophysiology to ensure the right patients get the right treatment. This becomes more challenging when patients have more than one disease requiring a targeted treatment. Autoimmune diseases commonly co-occur, and thus, multidisciplinary working is important in rheumatology. We present a case where a patient with a new diagnosis of alopecia areata on a background of rheumatoid arthritis was successfully treated with baricitinib monotherapy, with improvement in both conditions.<\/jats:p>","DOI":"10.1136\/bcr-2024-260021","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T01:35:20Z","timestamp":1729820120000},"page":"e260021","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["From joint pains to hair gains: baricitinib\u2019s double duty for rheumatoid arthritis and alopecia areata"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8253-3887","authenticated-orcid":false,"given":"Emer","family":"Gates","sequence":"first","affiliation":[{"name":"Rheumatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK"},{"name":"Medicine, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Takwale","sequence":"additional","affiliation":[{"name":"Dermatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Safwan","family":"Jamal","sequence":"additional","affiliation":[{"name":"Rheumatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"2025082700242908000_17.10.e260021.1","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","article-title":"The genetics of rheumatoid arthritis","volume":"59","author":"Dedmon","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"2025082700242908000_17.10.e260021.2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"2025082700242908000_17.10.e260021.3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00403-022-02444-x","article-title":"Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women","volume":"315","author":"Moseley","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"2025082700242908000_17.10.e260021.4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/ijt.ijt_49_20","article-title":"Anagen Effluvium after Methotrexate: An Idiosyncratic Reaction","volume":"12","author":"Sinha","year":"2020","journal-title":"Int J Trichol"},{"key":"2025082700242908000_17.10.e260021.5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","article-title":"Methotrexate for alopecia areata: A systematic review and meta-analysis","volume":"80","author":"Phan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025082700242908000_17.10.e260021.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu145"},{"key":"2025082700242908000_17.10.e260021.7","article-title":"Adalimumab-Induced Lupus Serositis: A Case Report and Review of the Literature","volume":"15","author":"Lee","year":"2023","journal-title":"Cureus"},{"key":"2025082700242908000_17.10.e260021.8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/clinpract11030055","article-title":"Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature","volume":"11","author":"Manzo","year":"2021","journal-title":"Clin Pract"},{"key":"2025082700242908000_17.10.e260021.9","doi-asserted-by":"crossref","first-page":"35330353","DOI":"10.3390\/jpm12030353","article-title":"Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis","volume":"12","author":"Cacciapaglia","year":"2022","journal-title":"J Pers Med"},{"key":"2025082700242908000_17.10.e260021.10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-023-00764-w","article-title":"Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)","volume":"24","author":"Kwon","year":"2023","journal-title":"Am J Clin Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-260021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:24:38Z","timestamp":1756279478000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-260021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,24]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/bcr-2024-260021"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-260021","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}